MarketScreener Editorial Features IXICO plc
Equities
IXI
GB00BFXR4C20
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 GBX | +4.44% |
|
+2.17% | 0.00% |
| 06-10 | Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test | AN |
| 06-10 | IXICO plc Announces FDA Clearance of New Alzheimer's Disease Blood Based Diagnostic Biomarker | CI |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- IXI Stock
- News IXICO plc
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition